We demonstrated the abundance of the IFNA17 protein in CHRM4-overexpressing cells and the serum of patients with metastatic prostate cancer, suggesting that IFNA17 is a potential prognostic marker for advanced prostate cancer. The gene discussed is IFNA17; the disease is metastatic prostate carcinoma.